Skip to main content
. 2012 Feb;81(2):113–119. doi: 10.1124/mol.111.076141

Fig. 5.

Fig. 5.

Lurasidone reverses NMDAR hypofunction in the PCP model of schizophrenia. A and B, dot plots showing the amplitude of NMDAR-EPSC in PFC pyramidal neurons from PCP-treated animals injected with lurasidone (0.1 mg/kg s.c.; A) or clozapine (5 mg/kg s.c.; B). Inset, representative NMDAR-EPSC traces. Scale bar, 50 pA, 100 ms.